Crizotinib induces apoptosis and gene expression changes in ALK+ anaplastic large cell lymphoma cell lines; brentuximab synergizes and doxorubicin antagonizes-Reference-Cited by-同舟云学术

Crizotinib induces apoptosis and gene expression changes in ALK+ anaplastic large cell lymphoma cell lines; brentuximab synergizes and doxorubicin antagonizes

Published:2018-04-26 Issue:8 Volume:65 Page:e27094
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Hudson Sandra¹,Wang Dongliang²,Middleton Frank³,Nevaldine Barbara H.¹,Naous Rana⁴,Hutchison Robert E.⁴^ORCID

Affiliation:

1. Department of Radiation Oncology; SUNY Upstate Medical University; Syracuse New York

2. Department of Public Health and Preventive Medicine; SUNY Upstate Medical University; Syracuse New York

3. Department of Neuroscience and Physiology; SUNY Upstate Medical University; Syracuse New York

4. Department of Pathology; SUNY Upstate Medical University; Syracuse New York

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference70 articles.

1. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells;Stein;Blood,1985

2. Pediatric lymphomas: recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhood;Murphy;Ann Oncol,1994

3. Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma;Sandlund;J Clin Oncol,1994

4. Anaplastic large cell lymphoma (Ki-1+/CD30+) in childhood;Vecchi;Med Pediatr Oncol,1993

5. ALK expression defines a distinct group of T/null lymphomas (“ALK lymphomas”) with a wide morphological spectrum;Falini;Am J Pathol,1998

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aggressive T‐cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management;American Journal of Hematology;2024-02-02

2. Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability;Frontiers in Oncology;2023-04-28

3. Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma;Cancers;2021-09-01

4. Therapeutic strategies to enhance crizotinib anti-tumor efficacy in ALK + ALCL;Therapeutic Strategies to Overcome ALK Resistance in Cancer;2021

5. Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target;Haematologica;2020-04-23